For pharma, volatility and value are two sides of the same coin
But beyond output consistency, a diversified manufacturing base is important: EDB
Singapore
FOR the four months to July, Singapore's export-oriented drug industry notched up double-digit yearly growth, while July exports surged a stunning 109 per cent - yet industry players are hard put to forecast a consistent trajectory.
Rather, the prognosis for the notoriously volatile sector is for it to hold "steady".
Given the growing regional demand, and the resources pumped in amid strong regulatory support, why is the sector so volatile? The answer lies in the dynamics of the business.
Pharmaceuticals are highly vulnerable to base-effect blips, no thanks to issues such as inventory stockpiling or changes in drugmaker portfolios.
"It's just a very volatile sector, due to changes in product mixes and maintenance shutdowns that are hard for outsiders to know," said Mer…
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Economy & Policy
Singapore’s inflation eases more than expected in March, with headline inflation at 2.5-year low
8 in 10 firms in S-E Asia, Greater China positive about business environment: UOB survey
Flexi-work request guidelines not meant to prescribe blanket outcomes for employers or influence hiring of workforce: SNEF
Daily Debrief: What Happened Today (Apr 23)
Daily Debrief: What Happened Today (Apr 24)
Daily Debrief: What Happened Today (Apr 22)